Ida Hed Myrberg

Karolinska Institutet — Sweden

Medicine · Health Sciences

18h-index1.2kcitations46works9.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Childhood Cancer Survivors' Quality of Life(8), Acute Lymphoblastic Leukemia research(7), Colorectal Cancer Surgical Treatments(5), Autoimmune and Inflammatory Disorders Research(5), Colorectal Cancer Screening and Detection(4)

Publications46 total

The impact of defunctioning ileostomies on postoperative kidney function in rectal cancer surgery
Colorectal Disease·2025Open Access
Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer
New England Journal of Medicine·2025
Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer
New England Journal of Medicine·2025· 27 cited
Anastomotic protection at a cost: the renal toll of defunctioning ileostomies in rectal cancer surgery
British journal of surgery·2025Open Access
Outcome After Surgery for Colon Cancer in a National Cohort of Patients With and Without Inflammatory Bowel Disease
Alimentary Pharmacology & Therapeutics·2025· 2 citedOpen Access
Exposure to androgen deprivation therapy and risk of anastomotic leakage after colorectal cancer surgery
Colorectal Disease·2025· 2 citedOpen Access
Does socioeconomic status influence the choice of surgical technique in abdominal rectal cancer surgery?
Colorectal Disease·2025Open Access
Development and validation of an anastomotic risk score for use in a randomized clinical trial on defunctioning stoma use in low anterior resection for rectal cancer
Colorectal Disease·2025· 1 citedOpen Access
Low-dose aspirin to reduce recurrence rate in colorectal cancer patients with PI3K pathway alterations: 3-year results from a randomized placebo-controlled trial.
Journal of Clinical Oncology·2025· 14 cited
Earnings and work loss after colon and rectal cancer: a Swedish nationwide matched cohort study
EClinicalMedicine·2024· 3 citedOpen Access
Diagnostic guidelines for familial hemophagocytic lymphohistiocytosis revisited
Blood·2024· 59 citedOpen Access
Autoimmune and Metabolic Diseases and the Risk of Early-Onset Colorectal Cancer, a Nationwide Nested Case–Control Study
Cancers·2023· 8 citedOpen Access
Are we passing the acceptable? Standard setting of theoretical proficiency tests for foreign‐trained dentists
European Journal Of Dental Education·2022· 12 citedOpen Access
DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma
JCI Insight·2022· 37 citedOpen Access
Time trends in occupational exposure to chemicals in Sweden: proportion exposed, distribution across demographic and labor market strata, and exposure levels
Scandinavian Journal of Work Environment & Health·2022· 12 citedOpen Access
Acute central nervous system toxicity during treatment of pediatric acute lymphoblastic leukemia: phenotypes, risk factors and genotypes
Haematologica·2022· 12 citedOpen Access
Statistical advising: Professional development opportunities for the biostatistician
Statistics in Medicine·2022· 11 citedOpen Access
Optical Coherence Tomography Identifies Visual Pathway Involvement Earlier than Visual Function Tests in Children with MRI-Verified Optic Pathway Gliomas
Cancers·2022· 8 citedOpen Access
ICU Admission in Children With Acute Lymphoblastic Leukemia in Sweden: Prevalence, Outcome, and Risk Factors.
PubMed·2021· 2 cited
DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma
2021· 3 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Anna Nilsson(10), Mats Heyman(9), Jan‐Inge Henter(9), Arja Harila‐Saari(8), Caroline Nordenvall(8), Susanna Ranta(7), Anna Martling(6), Sol Erika Boman(6), Riitta Niinimäki(5), Nikolas Herold(4), Sean G. Rudd(4), Torsten Schaller(4), Kjeld Schmiegelow(4), Joanna Banerjee(4), Martin Rutegård(4), Peter Matthiessen(4), Kumar Sanjiv(3), Cynthia B. J. Paulin(3), Juliane Kutzner(3), Per Kogner(3)